Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frauke Muecksch

Showing results (31-40 of 70) with videos related to

Pageof 7
Sort By:
Biorxiv : the Preprint Server for Biology|September 16, 2020
Enhanced SARS-CoV-2 Neutralization by Secretory IgA in vitroZijun Wang, Julio C C Lorenzi, Frauke Muecksch, et al.
Nature Communications|July 8, 2021
Mapping mutations to the SARS-CoV-2 RBD that escape binding by different classes of antibodiesAllison J Greaney, Tyler N Starr, Christopher O Barnes, et al.
Journal of Clinical Microbiology|September 12, 2020
Serological Assays Estimate Highly Variable SARS-CoV-2 Neutralizing Antibody Activity in Recovered COVID-19 PatientsLarry L Luchsinger, Brett P Ransegnola, Daniel K Jin, et al.
Biorxiv : the Preprint Server for Biology|March 24, 2021
Mutational escape from the polyclonal antibody response to SARS-CoV-2 infection is largely shaped by a single class of antibodiesAllison J Greaney, Tyler N Starr, Christopher O Barnes, et al.
Science Translational Medicine|December 8, 2020
Enhanced SARS-CoV-2 neutralization by dimeric IgAZijun Wang, Julio C C Lorenzi, Frauke Muecksch, et al.
The Journal of Experimental Medicine|November 19, 2020
Antibody potency, effector function, and combinations in protection and therapy for SARS-CoV-2 infection in vivoAlexandra Schäfer, Frauke Muecksch, Julio C C Lorenzi, et al.
Biorxiv : the Preprint Server for Biology|June 25, 2020
Measuring SARS-CoV-2 neutralizing antibody activity using pseudotyped and chimeric virusesFabian Schmidt, Yiska Weisblum, Frauke Muecksch, et al.
The Journal of Experimental Medicine|July 22, 2020
Measuring SARS-CoV-2 neutralizing antibody activity using pseudotyped and chimeric virusesFabian Schmidt, Yiska Weisblum, Frauke Muecksch, et al.
Medrxiv : the Preprint Server for Health Sciences|August 19, 2022
Antibody feedback regulation of memory B cell development in SARS-CoV-2 mRNA vaccinationDennis Schaefer-Babajew, Zijun Wang, Frauke Muecksch, et al.
Biorxiv : the Preprint Server for Biology|March 10, 2021
Multimeric nanobodies from camelid engineered mice and llamas potently neutralize SARS-CoV-2 variantsJianliang Xu, Kai Xu, Seolkyoung Jung, et al.
Pageof 7

Showing results (31-40 of 70) with videos related to

Sort By:
Pageof 7
Biorxiv : the Preprint Server for Biology|September 16, 2020
Enhanced SARS-CoV-2 Neutralization by Secretory IgA in vitroZijun Wang, Julio C C Lorenzi, Frauke Muecksch, et al.
Nature Communications|July 8, 2021
Mapping mutations to the SARS-CoV-2 RBD that escape binding by different classes of antibodiesAllison J Greaney, Tyler N Starr, Christopher O Barnes, et al.
Journal of Clinical Microbiology|September 12, 2020
Serological Assays Estimate Highly Variable SARS-CoV-2 Neutralizing Antibody Activity in Recovered COVID-19 PatientsLarry L Luchsinger, Brett P Ransegnola, Daniel K Jin, et al.
Biorxiv : the Preprint Server for Biology|March 24, 2021
Mutational escape from the polyclonal antibody response to SARS-CoV-2 infection is largely shaped by a single class of antibodiesAllison J Greaney, Tyler N Starr, Christopher O Barnes, et al.
Science Translational Medicine|December 8, 2020
Enhanced SARS-CoV-2 neutralization by dimeric IgAZijun Wang, Julio C C Lorenzi, Frauke Muecksch, et al.
The Journal of Experimental Medicine|November 19, 2020
Antibody potency, effector function, and combinations in protection and therapy for SARS-CoV-2 infection in vivoAlexandra Schäfer, Frauke Muecksch, Julio C C Lorenzi, et al.
Biorxiv : the Preprint Server for Biology|June 25, 2020
Measuring SARS-CoV-2 neutralizing antibody activity using pseudotyped and chimeric virusesFabian Schmidt, Yiska Weisblum, Frauke Muecksch, et al.
The Journal of Experimental Medicine|July 22, 2020
Measuring SARS-CoV-2 neutralizing antibody activity using pseudotyped and chimeric virusesFabian Schmidt, Yiska Weisblum, Frauke Muecksch, et al.
Medrxiv : the Preprint Server for Health Sciences|August 19, 2022
Antibody feedback regulation of memory B cell development in SARS-CoV-2 mRNA vaccinationDennis Schaefer-Babajew, Zijun Wang, Frauke Muecksch, et al.
Biorxiv : the Preprint Server for Biology|March 10, 2021
Multimeric nanobodies from camelid engineered mice and llamas potently neutralize SARS-CoV-2 variantsJianliang Xu, Kai Xu, Seolkyoung Jung, et al.
Pageof 7